QUOTED. Aug. 29, 2018. Christian Hoyer Millar.
Oxford Biodynamics is making moves to enter the Chinese market after welcoming on board new investor and strategic partner GL Capital, a Shanghai-based private equity firm specializing in health care. See what company CEO Christian Hoyer Millar said about it here.
"China is a huge health-care market and one we wanted to address. We were approached by a number of different parties in China to sign as partners, but we chose GL primarily because it’s a focused health-care fund." –Christian Hoyer Millar, CEO, Oxford Biodynamics
Click here for a free trial of Medtech Insight